Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Open Wound: early-phase trial registry
4 of 4 indexed Open Wound trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 4 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Open Wound: 4 US clinical trials tracked, 4 recruiting.
Open Wound is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is NuScience Medical Biologics, running 2 of these trials.
Enrollment posture brief
Registry condition open-wound
OPEN 4 | RECR 100% | LATE 0 | EARLY 2 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Open Wound lists 4 open slots (100% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Open Wound on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Open Wound is recruiting above its size-band peers.
4 of 4 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds
NuScience Medical Biologics
NCT06918561
Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds
University of California, Irvine
NCT05169814
Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers
Eluciderm
NCT07396376
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Open Wounds
NuScience Medical Biologics
NCT07041177
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Open Wound records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Open Wound trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Open Wound page
4 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Open Wound trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- NuScience Medical Biologics sponsors the most Open Wound trials on record, review their full trial history before evaluating a specific study. See NuScience Medical Biologics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Open Wound condition card totals 4 registered trials; most-linked intervention NeoThelium FT; top US site state Louisiana. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.